The landscape of dementia prognosis has evolved dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based assessments that could detect Alzheimer's pathology many years before signs or symptoms emerge. Though these technological improvements signify extraordinary progress in being familiar with neurodegenerative condition... https://pauls864gtl7.wikicommunication.com/user